Inge Verberk

20PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesPsychology of ageingNeurosciences not elsewhere classifiedGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.

|Mar 30, 2026
Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury.

Hadassa Kwetsie, Inge M W Verberk, Jans S van Ool

|Oct 01, 2025
Opposing views or like-minded? International Working Group and Alzheimer's Association criteria.

Inge M W Verberk, Argonde C van Harten, Wiesje M van der Flier

|Jun 09, 2025
Serum neurofilament light is superior to glial fibrillary acidic protein to distinguish sporadic frontotemporal dementia from late-onset primary psychiatric disorders: a retrospective DIPPA-FTD study.

Sterre Catharina Maria de Boer, Chiara Fenoglio, Andrea Arighi

|Sep 17, 2024
The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases.

Dea Gogishvili, Madison I J Honey, Inge M W Verberk

|Mar 01, 2024
Biomarker-based staging of Alzheimer disease: rationale and clinical applications.

Joseph Therriault, Suzanne E Schindler, Gemma Salvadó

Pageof 4

Frequent Collaborators

11 joint publications

Charlotte Teunissen

6 joint publications

Wiesje M van der Flier

3 joint publications

Kaj Blennow

3 joint publications

Lisa Vermunt